drugset

drugset / Trial / NCT00100113

Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1

NCT00100113 ↗

Phase 1 Unknown 24 enrolled National Institute on Drug Abuse (NIDA)

Treatment

Summary

The purpose of this study is to assess potential interactions between intravenous (IV) cocaine and 3 doses of GBR 12909.

Timeline

Start: 2004-06
Primary completion: —
Completion: 2005-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	vanoxerine	Small molecule	—	Oral

Indications